Burning Rock Biotech Limited
BNR
$4.52
-$0.18-3.83%
| 09/30/2024 | 03/31/2024 | 12/31/2023 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -82.29M | -92.43M | -92.43M | -100.39M |
| Total Depreciation and Amortization | -- | 18.21M | 18.21M | 18.21M | 16.99M |
| Total Amortization of Deferred Charges | -- | 269.80K | 269.80K | 269.80K | 471.30K |
| Total Other Non-Cash Items | -- | 45.36M | 44.57M | 44.57M | 40.59M |
| Change in Net Operating Assets | -- | -7.22M | -7.22M | -7.22M | -1.57M |
| Cash from Operations | -- | -25.67M | -36.61M | -36.61M | -43.92M |
| Capital Expenditure | -- | -1.12M | -1.12M | -1.12M | -9.89M |
| Sale of Property, Plant, and Equipment | -- | 11.60K | 11.60K | 11.60K | 339.70K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 41.00K | -220.00K | -220.00K | 7.56M |
| Cash from Investing | -- | -1.07M | -1.33M | -1.33M | -1.99M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -2.37M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -6.98M | -6.98M | -6.98M | -71.83M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -41.82M | -41.86M | -41.86M | 17.21M |
| Cash from Financing | -- | -6.74M | -6.75M | -6.75M | -7.90M |
| Foreign Exchange rate Adjustments | -- | 1.28M | 553.90K | 553.90K | 174.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -32.21M | -44.13M | -44.13M | -53.64M |
